The Lab to IPO Pathway gives universities a standard system, tools, processes and methodology to help TTOs and commercial teams improve decision making and reporting, align better with research publication/peer review processes, protect IP, and secure investment.
Researchers and academics are not always incentivised to commercialise.
Determining the direction of travel is not always straightforward and simple.
A clear rationale for commercialisation, funding and equity early on is critical.
Ensuring there is a steady, reliable and timely source of capital ensures success.
From simple user registration to project Disclosure & Validation, the PIPE Platform and Lab to IPO Pathway is designed to support the TTO and commercial team make better, standardised and systematic decisions. From the use of AI to the presentation of outcomes in a standard, easy to understand format, the PIPE Platform is a novel approach to university R&D/IP impact creation.
To patent or not to patent?
Researchers want to draft, peer review and publish without delay.
At the same time, TTOs and commercial teams need to consider IP protection and/or a patent application. It takes time and money to investigate prior art, to identify the inventive step, and submit a patent application if appropriate.
So there is a risk of conflict between these two work streams.
PIPE is designed to fix this.